Panel Discussion: Accelerating mRNA CGT Therapies: Balancing Phase-Appropriate Quality & CMC Complexity
2:30 pm - Thursday 1st October 2026
- How are emerging mRNA modalities in CGT changing the biggest process development and CMC challenges teams need to solve today?
- Where are current analytical and control strategies falling short when applied across diverse mRNA-enabled CGT applications – and how should they evolve?
- What does a truly scalable and flexible CMC framework look like when supporting multiple mRNA-driven CGT modalities with differing requirements?
